Davenport & Co’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$420K Buy
4,866
+878
+22% +$78K ﹤0.01% 1069
2026
Q2
$361K Buy
+3,988
New +$334K ﹤0.01% 1127
2024
Q4
– Sell
-3,031
Closed -$200K – 1169
2024
Q3
$200K Buy
+3,031
New +$220K ﹤0.01% 1110
2024
Q1
– Sell
-2,830
Closed -$216K – 1118
2023
Q4
$216K Buy
+2,830
New +$197K ﹤0.01% 996
2023
Q3
– Sell
-2,889
Closed -$273K – 1064
2023
Q2
$273K Buy
2,889
+42
+1% +$3.65K ﹤0.01% 924
2023
Q1
$236K Sell
2,847
-567
-17% -$44.6K ﹤0.01% 933
2022
Q4
$255K Sell
3,414
-2,986
-47% -$230K ﹤0.01% 867
2022
Q3
$529K Sell
6,400
-584
-8% -$56.2K ﹤0.01% 654
2022
Q2
$664K Sell
6,984
-482
-6% -$49.9K 0.01% 599
2022
Q1
$879K Buy
7,466
+416
+6% +$46.7K 0.01% 586
2021
Q4
$913K Buy
7,050
+240
+4% +$28K 0.01% 589
2021
Q3
$771K Buy
6,810
+442
+7% +$50.5K 0.01% 602
2021
Q2
$660K Buy
6,368
+3,639
+133% +$343K 0.01% 573
2021
Q1
$228K Sell
2,729
-400
-13% -$33.8K ﹤0.01% 730
2020
Q4
$285K Hold
3,129
– – ﹤0.01% 654
2020
Q3
$250K Sell
3,129
-846
-21% -$66K ﹤0.01% 625
2020
Q2
$275K Sell
3,975
-75
-2% -$5.33K ﹤0.01% 569
2020
Q1
$255K Sell
4,050
-468
-10% -$33.8K ﹤0.01% 531
2019
Q4
$351K Sell
4,518
-282
-6% -$22K ﹤0.01% 552
2019
Q3
$296K Hold
4,800
– – ﹤0.01% 565
2019
Q2
$296K Hold
4,800
– – ﹤0.01% 569
2019
Q1
$306K Sell
4,800
-90
-2% -$5.14K ﹤0.01% 533
2018
Q4
$250K Sell
4,890
-300
-6% -$15.2K ﹤0.01% 552
2018
Q3
$301K Buy
5,190
+210
+4% +$10.3K ﹤0.01% 551
2018
Q2
$242K Buy
+4,980
New +$232K ﹤0.01% 606

Other funds holding EW

Davenport & Co's EW Position: Q3 2026 in Review

Davenport & Co increased its Edwards Lifesciences (EW) stake by 22% in Q3 2026, buying an estimated $78K and bringing the position to 4,866 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #1069.

Davenport & Co first reported a position in EW in Q2 2018 and has held it in 25 quarters since. The position peaked at $913K in Q4 2021. 1,244 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Davenport & Co held 4,866 shares of Edwards Lifesciences worth $420K as of Q3 2026.
  • Davenport & Co bought 878 Edwards Lifesciences shares in Q3 2026, an estimated $78K.
  • Edwards Lifesciences made up ﹤0.01% of Davenport & Co's portfolio in Q3 2026, its #1069 holding.
  • Davenport & Co first reported a position in Edwards Lifesciences in Q2 2018 and has held it in 25 quarters since.
  • Davenport & Co's Edwards Lifesciences position peaked at $913K in Q4 2021.
  • 1,244 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Davenport & Co's 13F filing for Q3 2026, filed 14 Oct 2026.